Workup and Management for Infertility with Intermenstrual Spotting
This 34-year-old woman requires simultaneous evaluation of both her abnormal uterine bleeding and infertility, starting with transvaginal ultrasound (combined transabdominal and transvaginal with Doppler), followed by assessment of ovarian reserve, ovulatory function, tubal patency, and partner semen analysis.
Initial Imaging Evaluation
The first step is combined transabdominal and transvaginal ultrasound with Doppler, which is the most appropriate initial imaging study for abnormal uterine bleeding 1. This will evaluate for:
- Endometrial polyps
- Submucosal fibroids
- Adenomyosis
- Endometrial thickness and abnormalities
- Ovarian morphology (including polycystic ovarian morphology)
- Antral follicle count for ovarian reserve assessment 2
If the initial ultrasound is inconclusive or the uterus is incompletely visualized, sonohysterography should be performed if a polyp is suspected, or MRI pelvis without and with contrast if other pathology is suspected 1.
Infertility Workup Components
Given her age (34 years) and 7 years of attempting conception, she meets criteria for infertility evaluation. The essential components include 3:
Female Factor Assessment:
- Ovarian reserve testing: TSH, day 3 FSH, AMH, and antral follicle count on ultrasound
- Ovulatory function: Mid-luteal progesterone (day 21 of cycle) or ovulation predictor kits
- Tubal patency evaluation: Hysterosalpingography (HSG) is indicated to assess fallopian tube patency 2, 3
- Thyroid function: TSH to rule out thyroid dysfunction as cause of both bleeding and infertility 4
Male Factor Assessment:
Semen analysis should be obtained early in the workup, as male factor contributes to 40-50% of infertility cases 3. This is critical and should not be delayed.
Abnormal Bleeding Evaluation
For her 4-year history of intermenstrual spotting, additional considerations include:
- Endometrial biopsy is NOT immediately indicated in this case, as she is under 35 years without risk factors for endometrial cancer and does not have recurrent anovulation 4
- Pregnancy test (hCG) to exclude current pregnancy 5
- Complete blood count to assess for anemia from chronic bleeding 5
- Coagulation screening if heavy bleeding is present (von Willebrand disease screening) 4
Management Algorithm Based on Findings
If Structural Abnormalities Found (polyps, fibroids):
- Hysteroscopic polypectomy or myomectomy before attempting conception, as these can interfere with implantation 2, 4
If Ovulatory Dysfunction Identified:
- Address underlying cause (PCOS, thyroid dysfunction, hyperprolactinemia)
- Ovulation induction with clomiphene citrate or letrozole for fertility
- This simultaneously addresses both bleeding and infertility 4, 6
If Tubal Factor Identified:
- Referral to reproductive endocrinology for consideration of tubal surgery vs. IVF 2
If No Structural Cause Found and Bleeding Persists:
Since she desires pregnancy, avoid hormonal contraceptives for bleeding management. Instead:
Critical Pitfalls to Avoid
- Do not delay male partner evaluation - obtain semen analysis concurrently with female workup 3
- Do not start hormonal contraceptives for bleeding control in someone actively trying to conceive
- Do not perform endometrial biopsy routinely in women under 35 without risk factors 4
- Do not skip tubal patency testing - 14% of infertility is due to tubal damage 2
- Expedite evaluation given age 34 - she is approaching the threshold where evaluation should occur after only 6 months of trying 3
Timing Considerations
Given her age (34 years), treatment should be initiated promptly after diagnosis rather than waiting additional months 3. If unexplained infertility is diagnosed (normal ovulation, tubal patency, normal semen analysis), she should be referred to reproductive endocrinology for consideration of intrauterine insemination or IVF, as 30% of infertile couples have unexplained infertility 3.
The intermenstrual spotting may resolve once pregnancy is achieved or underlying causes (anovulation, structural lesions) are treated. Prioritize fertility evaluation and treatment over bleeding management, using non-hormonal options for bleeding control as needed.